EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

The Fibroblast Growth Factor signaling pathway

David M Ornitz, Nobuyuki Itoh

WIREs Developmental Biology · 2015-05 · 4 (3) · 215-266

DOI: 10.1002/wdev.176 ↗

At a glance

Übersichtsarbeit in WIREs Developmental Biology, published online on 2015-03-13. Written by David M Ornitz and 1 co-authors. Institution: Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA. Major MEDLINE topics: Models, Biological. Cited 1968 times so far (Crossref); 776 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NICHD NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The signaling component of the mammalian Fibroblast Growth Factor ( FGF ) family is comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF receptors ( FGFRs ). Interaction of FGF ligands with their signaling receptors is regulated by protein or proteoglycan cofactors and by extracellular binding proteins. Activated FGFRs phosphorylate specific tyrosine residues that mediate interaction with cytosolic adaptor proteins and the RAS‐MAPK , PI3K‐AKT , PLCγ , and STAT intracellular signaling pathways. Four structurally related intracellular non‐signaling FGFs interact with and regulate the family of voltage gated sodium channels. Members of the FGF family function in the earliest stages of embryonic development and during organogenesis to maintain progenitor cells and mediate their growth, differentiation, survival, and patterning. FGFs also have roles in adult tissues where they mediate metabolic functions, tissue repair, and regeneration, often by reactivating developmental signaling pathways. Consistent with the presence of FGFs in almost all tissues and organs, aberrant activity of the pathway is associated with developmental defects that disrupt organogenesis, impair the response to injury, and result in metabolic disorders, and cancer. WIREs Dev Biol 2015, 4:215–266. doi: 10.1002/wdev.176 This article is categorized under: Early Embryonic Development > Development to the Basic Body Plan Nervous System Development > Vertebrates: General Principles Birth Defects > Organ Anomalies

Subjects

MeSH terms (MEDLINE)

Models, BiologicalAnimalsCell DifferentiationCell MovementCell ProliferationEmbryonic DevelopmentEnergy MetabolismFibroblast Growth FactorsHomeostasisHumansOrganogenesisReceptors, Fibroblast Growth FactorSignal TransductionVoltage-Gated Sodium Channels

Substances

Receptors, Fibroblast Growth FactorVoltage-Gated Sodium ChannelsFibroblast Growth Factors

Authors and institutions

  • Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.

Funding

  • NICHD NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • Action on Hearing Loss
  • march of dimes
  • Ministry of Education, Science, Sports, and Culture of Japan

Cite

APA

Ornitz, D. M., & Itoh, N. (2015). The Fibroblast Growth Factor signaling pathway. WIREs Developmental Biology, 4(3), 215-266. https://doi.org/10.1002/wdev.176

Vancouver

Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. WIREs Developmental Biology. 2015;4(3):215-266. doi:10.1002/wdev.176

BibTeX
@article{Ornitz2015,
  author = {Ornitz, David M and Itoh, Nobuyuki},
  title = {The Fibroblast Growth Factor signaling pathway},
  journal = {WIREs Developmental Biology},
  year = {2015},
  volume = {4},
  number = {3},
  pages = {215--266},
  doi = {10.1002/wdev.176}
}
Start for free →